Literature DB >> 3485436

Arthroscopic treatment of the septic knee.

M J Smith.   

Abstract

Pyarthrosis of the knee was treated in 30 patients by arthroscopic decompression and lavage, coupled with parenteral and oral antibiotics. There were 21 men and nine women patients whose ages ranged from 6 months to 65 years of age. Twenty-two patients were considered to have a hematogenous origin as a cause of their pyarthrosis, and eight were caused by penetrating trauma. Twenty-eight of these patients had the onset of symptoms within 72 h prior to arthroscopy. Two adults had the onset of their symptoms 1 week prior to treatment. Follow-up has ranged from 6 months to 5 years. Staphylococcus aureus was cultured in 20 knees, Streptococcus pneumonia in three knees, Haemophilus influenzae in four knees, and Neisseria gonorrhoeae in one knee. The average hospital stay among 22 children aged 12 years or younger was 3.50 days. The other eight patients had an average hospital stay of 9.50 days. Three adults with diabetes and other medical problems, such as renal failure, had an average hospital stay of 17.33 days. Excellent results were obtained in 28 (93.3%) of 30 patients and good results were obtained in two (6.7%) of 30 patients. There were no poor results or recurrences, and no cases of osteomyelitis occurred. This method of treatment markedly reduces the morbidity and hospital stay of patients with a septic knee.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485436     DOI: 10.1016/s0749-8063(86)80007-x

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  15 in total

1.  Results of treatment of septic knee arthritis: a retrospective series of 40 cases.

Authors:  Laurent Balabaud; Jeannot Gaudias; Cyril Boeri; Jean-Yves Jenny; Pierre Kehr
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-12-06       Impact factor: 4.342

2.  [Stage-dependent arthroscopic treatment of knee joint infections].

Authors:  E Enderle; K-H Frosch
Journal:  Oper Orthop Traumatol       Date:  2013-06       Impact factor: 1.154

3.  Percutaneous endoscopic discectomy and drainage for infectious spondylitis.

Authors:  Shih-Chieh Yang; Tsai-Sheng Fu; Lih-Huei Chen; Chi-Chien Niu; Po-Liang Lai; Wen-Jer Chen
Journal:  Int Orthop       Date:  2006-09-05       Impact factor: 3.075

4.  Toxicity of antiseptics against chondrocytes: what is best for the cartilage in septic joint surgery?

Authors:  Eric Röhner; Paula Kolar; Joern B Seeger; Joerg Arnholdt; Kathi Thiele; Carsten Perka; Georg Matziolis
Journal:  Int Orthop       Date:  2011-01-16       Impact factor: 3.075

5.  Treatment of septic arthritis of the knee: a comparison between arthroscopy and arthrotomy.

Authors:  Christoph Böhler; Mirnic Dragana; Stephan Puchner; Reinhard Windhager; Johannes Holinka
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-05-28       Impact factor: 4.342

Review 6.  [Acute joint infection--diagnosis and treatment].

Authors:  J Jerosch
Journal:  Orthopade       Date:  2004-11       Impact factor: 1.087

7.  Knee joint infection after ACL reconstruction: prevalence, management and functional outcomes.

Authors:  R Torres-Claramunt; X Pelfort; J Erquicia; S Gil-González; P E Gelber; L Puig; J C Monllau
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-10-27       Impact factor: 4.342

8.  [Arthroscopic therapy algorithm for septic coxitis].

Authors:  M Kusma; O Steimer; M Dienst
Journal:  Unfallchirurg       Date:  2012-11       Impact factor: 1.000

9.  Current surgical practice for septic arthritis of the knee in the United States.

Authors:  David Jaffe; Timothy Costales; Julio J Jauregui; Scott Koenig; Tristan B Weir; Patrick Greenwell; Matthew Christian; R Frank Henn
Journal:  J Orthop       Date:  2021-04-22

10.  Polyhexanide and hydrogen peroxide inhibit proteoglycan synthesis of human chondrocytes.

Authors:  Eric Röhner; Paula Hoff; Tobias Winkler; Philipp von Roth; Jörn Bengt Seeger; Carsten Perka; Georg Matziolis
Journal:  J Histotechnol       Date:  2011-03       Impact factor: 0.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.